Story Emphasizes Record Investment, Top Talent, Innovative Research Collaborations, and Investments in Lab Space

Recently, Colorado BioScience Association collaborated with CNBC to champion our community and share our success stories. The resulting coverage emphasizes our ecosystem’s momentum, including record funding, top talent, innovative collaborations with our leading academic and research institutions, and investments in lab space.

“Investors from Colorado as well as across the coasts are seeing opportunities here,” said Elyse Blazevich, president and CEO of the Colorado Bioscience Association. “Our ecosystem has raised in excess of a billion dollars for the past seven consecutive years — and early-stage funding in Colorado in 2023 grew faster than other life sciences markets around the country.”

The story also includes interviews with:

• BioMed Realty CEO Tim Schoen on the company’s $625M investment in the Flatiron Park campus
• Edgewise Therapeutics Co-Founder & CEO Kevin Koch on the company’s growth in Boulder
• Dan Labarbera, Founding Director, Center for Drug Discovery, University of Colorado Anschutz Medical Campus, highlighting the connections among academia, clinicians, and commercial companies

Read the Full Story

CNBC Profile of Colorado Co-Founder Featured on Homepage  

Camila Uzcategui, Ph.D., CEO and Co-Founder of Vitro 3D, shown during her presentation to investors at the 2022 Rocky Mountain Life Sciences Investor & Partnering Conference, shared her steps for success and motivation to give back in CNBC’s In Pursuit of Success: Stories of Ambition and Achievement.  

“My passion for innovation led me to pursue a Ph.D., specializing in 3D printing for tissue engineering and regeneration. During this journey, I contributed to the development of technology that has the potential to create synthetic human organs, a breakthrough with far-reaching implications.” – Camila Uzcategui, Ph.D., CEO and Co-Founder, Vitro 3D